
The following is the author’s description of the photograph quoted directly from the photograph’s Flickr page. “Just wanted to test something with my ink refiller syringe. Filled with a oral-b mouthwash to give the greenish-blueish Max Payne valkyr effect. ” (Photo credit: Wikipedia)
MAPS technology may generate vaccines conferring strong immunity at reduced cost and risk
A new method of vaccine design, called the Multiple Antigen Presentation System (MAPS), may result in vaccines that bring together the benefits of whole-cell and acellular or defined subunit vaccination. The method, pioneered by researchers at Boston Children’s Hospital, permits rapid construction of new vaccines that activate mulitple arms of the immune system simultaneously against one or more pathogens, generating robust immune protection with a lower risk of adverse effects.
As reported by Fan Zhang, PhD, Ying-Jie Lu, PhD, and Richard Malley, MD, from Boston Children’s Division of Infectious Disease, in the Proceedings of the National Academy of Sciences on July 29, the method could speed development of new vaccines for a range of globally serious pathogens, or infectious agents.
Broadly speaking, the vaccines available today fall into two categories: whole-cell vaccines, which rely on weakened or killed bacteria or viruses; and acellular or subunit vaccines, which include a limited number of antigens—portions of a pathogen that trigger an immune response. Both approaches have advantages and disadvantages.
“Whole-cell vaccines elicit a broad range of immune responses, often just as an infection would, but can cause side effects and are hard to standardize,” said Malley. “Acellular vaccines can provide good early immunity with less risk of side effects, but the immune responses they induce wane with time.”
The MAPS method may allow vaccine developers to take a middle ground, where they can link multiple protein and polysaccharide (sugar) antigens from one or more pathogens together in a modular fashion, much as one would connect Lego blocks.
The resulting complex—which resembles a scaffold of polysaccharides studded with proteins—can stimulate both antibody and T-cell responses simultaneously much like whole-cell vaccines, resulting in stronger immunity to the source pathogen(s). However, because the composition of a MAPS vaccine is well defined and based on the use of isolated antigens (as one would find with an acellular vaccine) the risk of side effects should be greatly reduced.
For instance, mice injected with a MAPS vaccine combining proteins from tuberculosis (TB) and polysaccharides from Streptococcus pneumoniae (pneumococcus) mounted vigorous antibody and T-cell responses against TB, whereas those vaccinated with TB protein antigens alone mounted only an antibody response.
Similarly, 90 percent of mice given a MAPS-based vaccine containing multiple pneumococcal polysaccharide and protein antigens were protected from a lethal pneumococcus infection, mounting strong antibody and T-cell responses against the bacteria. By contrast, 30 percent of mice vaccinated with the same antigens in an unbound state survived the same challenge.
“The MAPS technology gives you the advantages of: whole-cell vaccines while being much more deliberate about which antigens you include; doing it in a quantitative and precise way; and including a number of antigens so as to try to replicate the effectiveness of whole-cell vaccination,” Malley explained. “The immunogenicity of these constructs is greater than the sum of their parts, somewhat because they are presented to the host as particles.”
The system relies on the interactions of two compounds, biotin and rhizavidin, rather than covalent binding as is used in most of the current conjugate vaccines. To build a MAPS vaccine, biotin is bound to the polysaccharide(s) of choice and rhizavidin to the protein(s). The biotin and rhizavidin then bind together through an affinity interaction analogous to Velcro. The construction process is highly efficient, significantly reducing the time and cost of vaccine development and production.
The Latest Bing News on:
Vaccine design
- Tuberculosis vaccine does not protect elderly against COVID-19: Researchon February 2, 2023 at 10:34 pm
This vaccine - the most widely administered vaccine in the world ... we can be proud of the fact that we were able to successfully design and conduct the study - the largest to date on this topic - in ...
- TB Vaccine Does Not Protect Elderly Against COVID-19on February 2, 2023 at 11:09 am
This vaccine - the most widely administered vaccine in the world ... we can be proud of the fact that we were able to successfully design and conduct the study - the largest to date on this topic - in ...
- Health Rounds: New vaccine design may improve effectivenesson February 2, 2023 at 9:42 am
"The blended mish-mosh works to some extent," but effectiveness can be improved by organizing vaccine components in specific ways, said Chad Mirkin, director of the International Institute for ...
- Global RNA Vaccine Advances Research Report 2022: Overcoming RNA Vaccine Manufacturing Bottlenecks to Meet Increased Demandon February 2, 2023 at 8:00 am
The "Advances and Growth Opportunities in RNA Vaccines" report has been added to ResearchAndMarkets.com's offering.
- Tuberculosis vaccine does not protect elderly against COVID-19, finds large Dutch studyon February 2, 2023 at 6:21 am
The tuberculosis vaccine (or BCG vaccine) does not protect the elderly with co-morbidities against disease symptoms caused by a coronavirus infection. This was reported in the BCG-PRIME study which ...
- Remodeling How Cancer Vaccines Are Designedon February 1, 2023 at 4:00 am
Researchers used chemistry and nanotechnology to change the structural location of adjuvants and antigens on and within a nanoscale vaccine to boost potency and performance.
- New Design Principles To Improve Cancer Vaccineson February 1, 2023 at 2:25 am
“Small changes in antigen placement on a vaccine significantly elevate cell-to-cell communication, cross-talk and cell synergy,” Mirkin said. “The developments made in this work provide a path forward ...
- Developing the Next Generation of SARS-CoV-2 Vaccineson January 31, 2023 at 4:09 pm
Researchers are urgently investigating new vaccines to provide more potent and durable protection from COVID-19.
- Scientists develop new design principles to improve cancer vaccine structureon January 31, 2023 at 1:58 pm
Researchers at Northwestern University International Institute for Nanotechnology IIN have discovered a novel method to significantly boost the effectivenes ...
- Transforming the way cancer vaccines are designed and madeon January 31, 2023 at 8:34 am
A new way to significantly increase the potency of almost any vaccine has been developed by researchers from the International Institute for Nanotechnology (IIN) at Northwestern University. The ...
The Latest Google Headlines on:
Vaccine design
[google_news title=”” keyword=”Vaccine design” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
MAPS-based vaccine
- Gardasil (HPV Vaccine) Market 2023 : Trend Analysis, Competitive Outlook of Top Industry Players and Future Expansion by 2028on February 2, 2023 at 8:33 pm
HPV is a group of viruses, the composition of a family, the virus morphology is similar, but the DNA restriction enzyme map is different ... the period 2017-2028. Based on Type, the market can be ...
- Global RNA Vaccine Advances Research Report 2022: Overcoming RNA Vaccine Manufacturing Bottlenecks to Meet Increased Demandon February 2, 2023 at 8:00 am
The "Advances and Growth Opportunities in RNA Vaccines" report has been added to ResearchAndMarkets.com's offering.
- COVID vaccine, testing sites set to close across Bay Areaon February 1, 2023 at 3:05 pm
Vaccines and testing will still be largely available through private healthcare providers and pharmacies. On Wednesday, Santa Clara County announced it would dismantle its three remaining vaccination ...
- Vaccines Global Market Opportunities And Strategies To 2031on February 1, 2023 at 2:55 am
provides the strategists; marketers and senior management with the critical information they need to assess the global vaccines market as it emerges from the COVID-19 shut down. Description:.New York, ...
- Cancer vaccines getting a boost from science born in Chicagoon January 31, 2023 at 7:27 pm
And now cancer vaccines are getting a boost from science born in Chicago. Northwestern University scientists have harnessed the power of nanotechnology to improve the way cancer vaccines work. They ...
- Covid Vaccine “Deserts” For Kids Under 5 Make It Almost Impossible For Parents To Find Shotson January 31, 2023 at 8:38 am
Experts in public health explain how to tell if you live in a "vaccine desert," and ways to find pediatric vaccination sites near you for Covid and other viruses.
- Scientists establish blueprint to redevelop cancer vaccineson January 31, 2023 at 8:01 am
Scientists have developed a Blueprint to redevelop and improve vaccine structure for seven different types of cancer.
- InstaDeep’s acquisition is a classic case of an African startup gone globalon January 31, 2023 at 2:59 am
InstaDeep’s deal — subject to regulatory approval and expected to close in the first half of this year — is quite intriguing, for a few reasons. First, when completed (at $682 million, adjusted in U.S ...
- COVID-19 in Maryland - DAILY UPDATES: Map, new case data, vaccine infoon January 30, 2023 at 4:00 pm
Submit food, cash, energy, emergency and aged/blind/disabled medical assistance applications online via the Department of Human Services website or the MyDHR portal. Medical Assistance ...
- Landmark vaccine for honeybeeson January 29, 2023 at 12:04 am
A biotech company in Georgia has received conditional approval from the US Department of Agriculture for the first vaccine for honeybees, a move scientists say could help pave the way for controlling ...
The Latest Google Headlines on:
MAPS-based vaccine
[google_news title=”” keyword=”MAPS-based vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]